Regina Abramovna Zhuk

This inventor holds 4 USPTO granted patents. Top assignees: Belorussky Nauchno-Issledovatelsky Institute Epidemiologii I, Institut Organicheskogo Sinteza Akademii Nauk Latviiskoi Ssr, Other. Active years: 1976-1990.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Regina Abramovna Zhuk. Retrieved from https://idiyas.com/inventor/regina-abramovna-zhuk

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

USPTO Granted Patents = 4

% Patents Active = 100.0

Average Co-Inventor Count = 4.6

ph-index = 1

Forward Citations = 4(Granted Patents)

Company Filing History:

1 out of 1

Belorussky Nauchno-Issledovatelsky Institute Epidemiologii I

patent

1 out of 7

Institut Organicheskogo Sinteza Akademii Nauk Latviiskoi Ssr

patents

3 out of 834,601

Other

patents

where one patent can have more than one assignee

Years Active: 1976-1990

Loading Chart...

4 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 4916225 - 9-substituted guanines (1990-04-10),

2. 4232149 - 1-(5-Fluoruracil-1)-2,5-di-O-acetyl-.beta.-D-glucofuranurono-6,3-lactone (1980-11-04),

3. 3954760 - Process for producing N.sub.1 -(.alpha.-butyrolactone- and N.sub.1 (.alpha. (1976-05-04),

4. 3947444 - Process for producing N.sub.1 -(Dihydroxyalkyl)-5-substituted uracils (1976-03-30),

Title: Regina Abramovna Zhuk: A Pioneer in Antiblastic Research

Introduction

Regina Abramovna Zhuk is a notable inventor based in Riga, SU. She has made significant contributions to the field of medicinal chemistry, particularly in the development of antiblastic agents. With a total of 4 patents to her name, her work has garnered attention for its innovative approaches to cancer treatment.

Latest Patents

Among her latest patents, Regina has developed compounds such as 9-substituted guanines and 1-(5-Fluoruracil-1)-2,5-di-O-acetyl-.beta.-D-glucofuranurono-6,3-lactone. These substances have demonstrated marked antiblastic action and are noted for being less toxic compared to existing preparations with similar effects. The formula for her latest invention is ##STR1##, showcasing her commitment to advancing therapeutic options in oncology.

Career Highlights

Throughout her career, Regina has worked at the Institut Organicheskogo Sinteza Akademii Nauk Latviiskoi Ssr, where she has been instrumental in various research projects. Her innovative spirit and dedication to her field have positioned her as a respected figure in medicinal chemistry.

Collaborations

Regina has collaborated with esteemed colleagues such as Solomon Aronovich Giller and Anna Eduardovna Berzinya. These partnerships have enriched her research and contributed to the advancement of her projects.

Conclusion

Regina Abramovna Zhuk's contributions to the field of antiblastic research highlight her as a pioneering inventor. Her innovative patents and collaborative efforts continue to influence the landscape of cancer treatment.

Profile summary based on public USPTO records.

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]